Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase D and raptor
US8278263B2 · kind B2 · utility
0Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 3, 2007 |
| Grant date | Oct 2, 2012 |
| Priority date | — |
| Expiry date | Oct 2, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/916
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of regulating mammalian target-of-rapamycin (mTOR) by regulating a phospholipase D (PLD) activity that generates a complex with mTOR. Further, the present invention also relates to a method of screening inhibitors of mTOR, and a method and a composition for treating mTOR-related metabolic diseases by inhibiting mTOR.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.